25SD04

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name25SD04
Drug Alias Namediabetic complication therapy (Biomedical Frontiers)25SD04
ClassificationSmall molecules
Mechanisms of ActionChelating agents
TargetsUpdating
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomedical Frontiers Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomedical Frontiers Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A